Montefiore Deal to Take Over Albert Einstein College of Medicine Delayed
The planned takeover of Yeshiva University’s Albert Einstein College of Medicine by a Bronx hospital chain has been delayed, the Forward has learned.
Montefiore Health Systems was supposed to take over financial and operational control of Einstein on July 1.
But a spokeswoman for Montefiore said July 31 that an agreement between Y.U. and Montefiore had still not been reached.
The spokeswoman, Tracy Gurrisi, said both sides had taken “significant steps toward a final agreement” on the deal, which will see Y.U. remain as the degree-granting institution.
But, citing the “highly complex legal and regulatory” nature of the deal, Gurrisis said the two sides now hoped to finalize an agreement by September 1.
A spokesman for Y.U. released the same statement to the Forward later the same day.
Y.U. has faced annual operating deficits in the tens of millions of dollars for the past seven years. Last year’s deficit was $84 million.
Consultants brought in to stem the losses identified Einstein as being responsible for about two-thirds of those deficits.
Y.U.’s president, Richard Joel, has told staff and students that the deal to unload Einstein will significantly reduce the university’s financial problems.
Contact Paul Berger at berger@forward.com or on Twitter @pdberger
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.
If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.
Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism.
— Rachel Fishman Feddersen, Publisher and CEO